TY  - JOUR
AU  - Rodríguez Antolín, A
AU  - Martínez-Piñeiro, L
AU  - Jiménez Romero, M E
AU  - García Ramos, J B
AU  - López Bellido, D
AU  - Muñoz Del Toro, J
AU  - García García-Porrero, A
AU  - Gómez Veiga, F
PY  - 2019
DO  - 10.1186/s12894-019-0527-8
UR  - http://hdl.handle.net/10668/14878
T2  - BMC urology
AB  - Fatigue is one of the most prevalent symptoms among cancer patients. Specifically, in metastatic castration-resistant prostate cancer (mCRPC) patients, fatigue is the most common adverse event associated with current treatments. The purpose of this...
LA  - en
KW  - BFI questionnaire
KW  - Castration-resistant prostate cancer
KW  - FACT-P questionnaire
KW  - Fatigue
KW  - Quality of life
KW  - Aged
KW  - Aged, 80 and over
KW  - Cross-Sectional Studies
KW  - Fatigue
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prevalence
KW  - Prostatic Neoplasms, Castration-Resistant
KW  - Quality of Life
TI  - PREVALENCE OF FATIGUE AND IMPACT ON QUALITY OF LIFE IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: the VITAL study.
TY  - research article
VL  - 19
ER  -